The Invesco Pharmaceuticals ETF (PJP) is designed to mirror the performance of the Dynamic Pharmaceutical Intellidex Index. This Fund typically allocates a minimum of 90% of its total assets to the common stocks that comprise this underlying Index. The Index itself aims to generate capital appreciation by rigorously assessing companies based on a diverse range of investment criteria, such as share price momentum, earnings growth, operational quality, management initiatives, and overall value.